Novavax | NVAX - Cost Of Sales

Name: Novavax | NVAX - Cost Of Sales
Creator: TRADING ECONOMICS
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Novavax,NVAX,Cost,Of,Sales,stock,equity,live,intraday,earnings,share,price,historical data,chart,calendar,dividend,yield,news

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

Features Questions? Contact us Already a Member? Login

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us

Please Paste this Code in your Website

width

height

Preview

Novavax

Novavax reported $34.09M in Cost of Sales for its fiscal quarter ending in March of 2023.

	Cost Of Sales		Date
Adma Biologics ADMA:US	USD 40.5M	4.7M	Mar/2023
Agenus AGEN:US	USD 2.29M	5.4M	Mar/2023
AstraZeneca AZN:LN	USD 2.05B	458M	Mar/2023
BioCryst Pharmaceuticals BCRX:US	USD 938K	1.56M	Mar/2023
Dynavax Technologies DVAX:US	USD 14.71M	62.78M	Mar/2023
GlaxoSmithKline GSK:LN	GBP 1.9B	274M	Mar/2023
MannKind MNKD:US	USD 16.21M	89K	Mar/2023
Merck & Co MRK:US	USD 3.35B	491M	Mar/2023
Moderna Inc MRNA:US	USD 792M	1.13B	Mar/2023
Novartis NVS:US	USD 3.83B	8M	Mar/2023
Novavax NVAX:US	USD 34.09M	147.68M	Mar/2023
Peregrine Pharmaceuticals PPHM:US	USD 28.19M	2.42M	Dec/2022
Pfizer PFE:US	USD 5.03B	4.8B	Mar/2023
Sarepta Therapeutics SRPT:US	USD 35.02M	4.22M	Mar/2023
TG Therapeutics TGTX:US	USD 857K	854K	Mar/2023